Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TYVASO DPI
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants
- Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
- Pulmonary Hypertension SOLAR
- Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
- Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
- Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
- Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
- Acute Effects of Inhaled Treprostinil in Fontan Patients
- An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
- Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
- Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
- Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
- Beraprost-314d Added-on to Tyvaso® (BEAT)
- Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
- Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
- A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).
- Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
- Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
- Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
- Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
Clinical trials list
click for details